PubMed,
Journal Year:
2022,
Volume and Issue:
11(4), P. 306 - 319
Published: Jan. 1, 2022
Alternative
pathways
frequently
operate
as
the
origins
of
resistance
to
drugs
that
block
vascular
endothelial
growth
factor
(VEGF)
pathway.
To
find
possible
therapeutic
targets
and
indicators,
this
study
explored
VEGF
pathway
how
miRNAs
control
it
in
recurrent
glioblastoma
multiforme
(rGBM).
Differentially
expressed
(DEmiRNAs)
were
identified
by
using
GBM
GSE
profiles
(GSE32466).
containing
DEmiRNAs,
genes,
their
related
DIANA-miRPath
v3.0
ToppGene
database
utilized.
linked
signaling
interactional
DEmiRNAs
discovered
extracting
common
pathways.
The
ability
these
distinguish
rGBM
patients
from
those
with
primary
was
assessed
ROC
analysis.
revealed
rGBM,
30
significantly
up-regulated
49
considerably
down-regulated.
Among
them,
connected
22
29
down-regulated
miRNAs.
MAPK
shared
most
genes
pathway,
accounting
for
1,014
interacting
which
have
interactions
genes.
Furthermore,
14
having
a
great
deal
potential
molecular
biomarkers
rGBM.
results
indicate
is
regulated
number
interrelated
hold
promise
targets,
offering
possibilities
novel
therapy
strategies
aiding
diagnosis
prognosis.
Epigenomes,
Journal Year:
2024,
Volume and Issue:
8(2), P. 14 - 14
Published: April 1, 2024
Alzheimer’s
Disease
(AD)
is
a
complex
disease
and
the
leading
cause
of
dementia
in
older
people.
We
aimed
to
uncover
aspects
AD’s
pathogenesis
that
may
contribute
drug
repurposing
efforts
by
integrating
DNA
methylation
genetic
data.
Implementing
network-based
tool,
dense
module
search
genome-wide
association
studies
(dmGWAS),
we
integrated
large-scale
GWAS
dataset
with
data
identify
gene
network
modules
associated
AD.
Our
analysis
yielded
286
significant
modules.
Notably,
foremost
included
BIN1
gene,
showing
largest
signal,
GNAS
most
significantly
hypermethylated.
conducted
Web-based
Cell-type-Specific
Enrichment
Analysis
(WebCSEA)
on
genes
within
top
10%
dmGWAS
modules,
highlighting
monocyte
as
cell
type
(p
<
5
×
10−12).
Functional
enrichment
revealed
Gene
Ontology
Biological
Process
terms
relevant
AD
pathology
(adjusted
p
0.05).
Additionally,
target
identified
five
FDA-approved
targets
(p-value
=
0.03)
for
further
research.
In
summary,
integration
epigenetic
signals
unveiled
new
interactions
related
AD,
offering
promising
avenues
future
studies.
Research Square (Research Square),
Journal Year:
2023,
Volume and Issue:
unknown
Published: April 20, 2023
Abstract
Glioblastomas
are
highly
aggressive
brain
tumors
for
which
therapeutic
options
very
limited.
In
a
quest
new
anti-glioblastoma
drugs,
we
focused
on
specific
structural
modifications
of
benzoyl-phenoxy-acetamide
(BPA)
present
in
common
lipid-lowering
drug,
fenofibrate,
and
our
first
prototype
glioblastoma
PP1.
Here,
propose
extensive
computational
analyses
to
improve
selection
the
most
effective
drug
candidates.
Initially
over
100
BPA
variations
were
analyzed
their
physicochemical
properties
such
as
water
solubility
(-logS),
calculated
partition
coefficient
(ClogP),
probability
BBB
crossing
(BBB_SCORE),
CNS
penetration
(CNS-MPO)
cardiotoxicity
(hERG),
evaluated.
This
integrated
approach
allowed
us
select
pyridine
variants
that
show
improved
penetration,
solubility,
low
cardiotoxicity.
Herein
top
24
compounds
synthesized
cell
culture.
Six
them
demonstrated
toxicity
with
IC50
ranging
from
0.59
3.24mM.
Importantly,
one
compounds,
HR68,
accumulated
tumor
tissue
at
3.7+/-0.5mM,
exceeds
its
(1.17mM)
by
3-fold.
Das
Glioblastom
ist
eine
tödliche
maligne
Erkrankung
des
zentralen
Nervensystems.
Etablierte
Therapiekonzepte
resultieren
in
einer
Fünfjahresüberlebensrate
von
fünf
Prozent.
Die
derart
infauste
Prognose
wird
unter
anderem
bedingt
durch
die
Heterogenität
Tumors.
Insbesondere
Population
stammzellartiger
Zellen
Verantwortung
für
Resistenz
und
Rekurrenz
Glioblastoms
zugesprochen.
genuine
Plastizität
mit
entsprechender
Fähigkeit
zur
Änderungen
tumorweiter
Expressionsprofile
Ausbildung
einzigartiger
funktioneller
Fähigkeiten
kann
ohne
gezielte
Beeinträchtigung
stammzellartigen
womöglich
nicht
ausreichend
überwunden
werden.
Als
Urheber
kritischer
Eigenschaften
erscheint
erfolgreiche
Elimination
dieser
innerhalb
notwendig
um
nachhaltige
Therapieerfolge
zu
erzielen.
Mögliche
Strategien
der
setzen
an
Differenzierung
Ausbeutung
stammzelltypischer
Signalwege
Modulation
an.
Hierdurch
sollen
zentrale
Zellen,
wie
Selbsterneuerung,
gegenüber
Strahlen-
Chemotherapie
erneute
Formation
heterogener
Tumore,
Zentrale
zelluläre
Prozesse,
welche
zum
Erhalt
Zustandes
beitragen,
sind
Hedgehog-
Notch-Signalweg.
Einer
wohnt
effektiven
zentraler
inne.
Neben
diesen
Signalwegen
gibt
es
Reihe
weiterer
welchen
Urheberschaft
zugesprochen
wird.
Hierzu
zählt
beispielweise
Prozess
Autophagie.
Autophagie
ein
hochkonservierter
zellulärer
Mechanismus
Selbsterneuerung
Selbstdegradation
fehlerhafter
Komponenten.
Gleichzeitig
Überaktivität
einem
spezifischen,
autophagischen
Zelltod
beitragen.
dieses
Dualismus
Vielzahl
Tumoren,
so
auch
im
Glioblastom,
das
Schicksal
tumorfördernden
antitumorale
ändern.
Im
Rahmen
Arbeit
wurde
erstmalig
Beeinflussung
ihrer
zellulären
Prozesse
mittels
kombinierter
Therapie
Arsentrioxid
oder
GANT
(-)-Gossypol
gezeigt.
wirkt
unspezifisch
als
Inhibitor
Notch-
Hedgehog-Signalweg.
Diese
Inhibition
den
untersuchten
nachgewiesen
führte
Reduktion
stammzelltypischen
Markerproteinen
Tumorgenese
-vitro
ex
-vivo,
sowie
Sensitivierung
strahleninduzierten
Schäden.
Gegenüber
spezifischen
Hedgehog-Inhibition
GANT-vermittelte
Bindung
Gli-Transkriptionsfaktoren
zeigten
sich
deutliche
Vorteile
dualen
hinsichtlich
genannten
Eigenschaften.
Kombination
Substanzen
dem
pan-Bcl-Inhibitor
synergistischen
Steigerung
antitumoralen
Effekte.
Gliomzellen
insbesondere
Maschinerie
Auslösung
eines
Zelltodes
Verbindung
gebracht.
Ergebnisse
weisen
parallele
Signalweginteraktionen
effektiver
DNA-Damage-Response-Systems
Proteins
CHEK
kausalen
Synergismus
aus.
beobachteten
typischen
implizieren
lohnende
Folgeuntersuchungen
weiteren
Evaluation
Effekte
zukünftig
translationale
Ableitungen
erlauben.
seine
lassen
erfolgreich
multiple
Eingriffe
unterschiedliche
hierunter
Hedgehog-Signaling,
modulieren.
könnten
eventuell
effektiv
verändert
PubMed,
Journal Year:
2022,
Volume and Issue:
11(4), P. 306 - 319
Published: Jan. 1, 2022
Alternative
pathways
frequently
operate
as
the
origins
of
resistance
to
drugs
that
block
vascular
endothelial
growth
factor
(VEGF)
pathway.
To
find
possible
therapeutic
targets
and
indicators,
this
study
explored
VEGF
pathway
how
miRNAs
control
it
in
recurrent
glioblastoma
multiforme
(rGBM).
Differentially
expressed
(DEmiRNAs)
were
identified
by
using
GBM
GSE
profiles
(GSE32466).
containing
DEmiRNAs,
genes,
their
related
DIANA-miRPath
v3.0
ToppGene
database
utilized.
linked
signaling
interactional
DEmiRNAs
discovered
extracting
common
pathways.
The
ability
these
distinguish
rGBM
patients
from
those
with
primary
was
assessed
ROC
analysis.
revealed
rGBM,
30
significantly
up-regulated
49
considerably
down-regulated.
Among
them,
connected
22
29
down-regulated
miRNAs.
MAPK
shared
most
genes
pathway,
accounting
for
1,014
interacting
which
have
interactions
genes.
Furthermore,
14
having
a
great
deal
potential
molecular
biomarkers
rGBM.
results
indicate
is
regulated
number
interrelated
hold
promise
targets,
offering
possibilities
novel
therapy
strategies
aiding
diagnosis
prognosis.